Dr. Shekar Patil
MD
Renowned Medical Oncologist | Visionary Leader in Cancer Treatment & Research
Dr. Shekar Patil stands as a pillar of excellence in the field of oncology, with a distinguished career that spans decades of groundbreaking work in cancer treatment and research. Revered for his innovative approaches, Dr. Patil has transformed the landscape of oncology through his mastery of advanced radiotherapy techniques, chemotherapy protocols, and bone marrow transplantation. His unparalleled expertise encompasses the full spectrum of cancer care, from conventional treatments to cutting-edge therapies for solid tumors, hematological malignancies, and complex gynecological cancers.
Dr. Patil’s work not only improves patient outcomes but shapes the future of cancer treatment, making him a trusted advisor and thought leader in the global medical community.
1. Areas of Expertise
- Pioneering both conventional and high-dose radiotherapy for complex solid and hematological cancers, enhancing treatment precision and efficacy.
- Leading innovations in intraperitoneal chemotherapy for advanced ovarian cancer, offering hope to patients with limited options.
- Championing concurrent radiation and chemotherapy for a wide range of carcinomas, ensuring integrated and effective care.
- A visionary in bone marrow transplantation, transforming outcomes for patients with leukemia and other blood-related disorders.
- Breakthrough research in the oral recombination of human lactoferrin with carboplatin chemotherapy in gynecological malignancies, a unique approach that pushes the boundaries of cancer care.
Extensive expertise in treating lymphoma and acute leukemia, contributing to life-saving advances in oncology.
2. Research & Publications
Dr. Patil’s contributions to oncological research have not only enriched the scientific community but have redefined clinical practices. His extensive publication record highlights his relentless pursuit of knowledge and his commitment to pushing the boundaries of cancer treatment. Some of his key publications include:
- FDG-PET Metabolic vs CT Anatomical Monitoring of Tumor Response to Anterior Chemotherapy in Breast Carcinoma – The Uncertainties
- Cancer Therapy & Oncology International Journal, 2021 – A trailblazing study addressing the complexities of tumor response evaluation.
- Landscape of Clinically Actionable Mutations in Breast Cancer: A Cohort Study
- Translational Oncology, 2021 – A pivotal work in identifying actionable mutations, shaping personalized treatment plans for breast cancer patients.
- Long-term Effectiveness of Lycopene in the Management of Oral Submucous Fibrosis (OSMF): A 3-year Follow-up Study
- Journal of Oral Pathology & Medicine, 2020 – A landmark study demonstrating the impact of innovative therapies on oral cancer.
- Circulating Tumor Cells in Head and Neck Cancers: Biological Insights.
- Journal of Oral Pathology & Medicine, 2020 – A forward-thinking exploration into the role of circulating tumor cells in cancer progression.
- Palbociclib in Hormone-Positive Metastatic Breast Cancer: A Real-World Multicenter Indian Experience
- Journal of Clinical Oncology, 2020 – Offering vital real-world insights into the use of targeted therapies in metastatic breast cancer.
- Clinical Profile of Carcinoma Breast Patients Treated with Trastuzumab: A Single Centre Study
- Advances in Breast Cancer Research, 2020 – A comprehensive study on the efficacy of life-extending treatments for breast cancer patients.